3-(1-PIPERIDINYLMETHYL)-5-NITRO-1H-INDOLE, 95.0%, 5g

5-Methoxypyrimidin-4(1H)-one, 95.0%, 250mg

Triacétine, min.99%, 100 ml, emballage en verre

3-Methyl-1-[2-(trifluoromethyl)phenyl]-1H-pyrazol-5-amine, 95.0%, 5g

5-Méthoxyindole, min 98%, pour synthèse, 25 g, emballage verre

(Trans,trans)-4-methoxy-4'-propyl-1,1'-bi(cyclohexane), 97.0%, 5g

3,5-Dinitropyridine-2,6-diamine, 95.0%, 1g

4-Phenylbutanoylchloride, 97.0%, 5g

2,4-Dimethoxybenzoic acid, 95.0%, 500g

Ethyl 2-amino-3-bromobenzoate, 95%, 1g

((Z)-2-((3S,5R)-3,5-bis((tert-butyldimethylsilyl)oxy)-2-methylenecyclohexylidene)ethyl)diphenylphosphine oxide, 98%, 250mg

2,6-DIBROMO-N-METHYLPYRIDIN-3-AMINE, 95%, 250mg

4-Methoxy-2,5-dimethylfuran-3(2H)-one, 95.0%, 250g